Clari Vest Asset Management LLC Eagle Pharmaceuticals, Inc. Transaction History

Clari Vest Asset Management LLC

$1 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$15.21 - $22.88 $137,346 - $206,606	-9,030 Reduced 28.86%	22,262 $351,000
Q2 2023 Aug 14, 2023	BUY	$17.74 - $31.87 $123,967 - $222,707	6,988 Added 28.75%	31,292 $608,000
Q1 2023 May 08, 2023	BUY	$25.06 - $34.09 $776 - $1,056	31 Added 0.13%	24,304 $690,000
Q4 2022 Feb 14, 2023	SELL	$24.98 - $39.77 $5,395 - $8,590	-216 Reduced 0.88%	24,273 $709,000
Q3 2022 Nov 10, 2022	SELL	$26.42 - $47.12 $713 - $1,272	-27 Reduced 0.11%	24,489 $646,000
Q2 2022 Aug 12, 2022	SELL	$41.26 - $51.35 $273,553 - $340,450	-6,630 Reduced 21.29%	24,516 $1.09 Million
Q1 2022 May 04, 2022	BUY	$44.58 - $52.6 $289,101 - $341,111	6,485 Added 26.3%	31,146 $1.54 Million
Q4 2021 Feb 14, 2022	SELL	$45.82 - $56.9 $42,062 - $52,234	-918 Reduced 3.59%	24,661 $1.26 Million
Q3 2021 Nov 08, 2021	BUY	$43.79 - $55.78 $646,603 - $823,647	14,766 Added 136.56%	25,579 $1.43 Million
Q2 2021 Aug 09, 2021	BUY	$36.86 - $44.5 $921 - $1,112	25 Added 0.23%	10,813 $463,000
Q1 2021 May 13, 2021	SELL	$40.32 - $50.97 $739,468 - $934,789	-18,340 Reduced 62.96%	10,788 $450,000
Q4 2020 Feb 09, 2021	SELL	$41.72 - $51.34 $662,054 - $814,714	-15,869 Reduced 35.27%	29,128 $1.36 Million
Q3 2020 Nov 09, 2020	SELL	$37.02 - $51.28 $54,197 - $75,073	-1,464 Reduced 3.15%	44,997 $1.91 Million
Q2 2020 Aug 12, 2020	BUY	$43.24 - $55.02 $33,727 - $42,915	780 Added 1.71%	46,461 $2.23 Million
Q1 2020 May 04, 2020	BUY	$34.37 - $60.07 $31,104 - $54,363	905 Added 2.02%	45,681 $2.1 Million
Q4 2019 Feb 12, 2020	SELL	$54.32 - $64.31 $1.07 Million - $1.27 Million	-19,737 Reduced 30.59%	44,776 $2.69 Million
Q3 2019 Nov 12, 2019	SELL	$53.25 - $59.98 $53,250 - $59,980	-1,000 Reduced 1.53%	64,513 $3.65 Million
Q2 2019 Aug 16, 2019	BUY	$46.61 - $58.45 $672,442 - $843,258	14,427 Added 28.24%	65,513 $3.65 Million
Q1 2019 May 13, 2019	SELL	$38.66 - $51.82 $105,155 - $140,950	-2,720 Reduced 5.06%	51,086 $2.58 Million
Q4 2018 Feb 05, 2019	BUY	$36.72 - $67.73 $513,015 - $946,255	13,971 Added 35.07%	53,806 $2.17 Million
Q3 2018 Nov 07, 2018	SELL	$66.65 - $83.86 $40,989 - $51,573	-615 Reduced 1.52%	39,835 $2.76 Million
Q2 2018 Aug 10, 2018	BUY	$51.25 - $76.62 $2.07 Million - $3.1 Million	40,450 New	40,450 $3.06 Million

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.

Account